Outcome measures and implications for sample-size calculations

Journal of Bone and Joint Surgery

Volumn 91, Issue SUPPL. 3, 2009, Pages 35-40

  Zlowodzki, Michael ^a   Bhandari, Mohit ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BINOMIAL DISTRIBUTION; FALSE POSITIVE RESULT; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SAMPLE SIZE; TREATMENT OUTCOME; ARTICLE; HUMAN; METHODOLOGY; ORTHOPEDICS; OUTCOME ASSESSMENT; PATIENT;

HUMANS; ORTHOPEDICS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT DROPOUTS; QUALITY OF LIFE; RESEARCH DESIGN; SAMPLE SIZE;

EID: 66349107382     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.H.01602     Document Type: Review

References (18)

1. Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 health survey: manual and interpretation guide. Boston: The Health Institute, New England Medical Center; 1996.
2. EuroQol - a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990;16:199-208.
3. Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996;29:602-8. Erratum in: Am J Ind Med. 1996;30:372.
4. Bonferroni CE. Il calcolo delle assicurazioni su gruppi di teste. In: Studi in onore del Professore Salvatore Ortu Carboni. Rome; 1935. p 13-60.
5. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407-15.
6. Hays RD, Farivar SS, Liu H. Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD. 2005;2:63-7.
7. Wyrwich KW, Metz SM, Kroenke K, Tierney WM, Babu AN, Wolinsky FD. Measuring patient and clinician perspectives to evaluate change in health-related quality of life among patients with chronic obstructive pulmonary disease. J Gen Intern Med. 2007;22:161-70.
8. Wyrwich KW, Nienaber NA, Tierney WM, Wolinsky FD. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care. 1999;37:469-78.
9. Johnson JA, Coons SJ, Ergo A, Szava-Kovats G. Valuation of EuroQOL (EQ-5D) health states in an adult US sample. Pharmacoeconomics. 1998;13:421-33.
10. Swiontkowski MF, Engelberg R, Martin DP, Agel J. Short musculoskeletal function assessment questionnaire: validity, reliability, and responsiveness. J Bone Joint Surg Am. 1999;81:1245-60.
11. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-83.
12. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
13. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582-92.
14. Miller GA. The magic number seven plus or minus two: some limits on our capacity for processing information. Psychol Rev. 1956;63:81-97.
15. Sung J, Siegel J, Tornetta P, Bhandari M. The orthopaedic trauma literature: an evaluation of statistically significant findings in orthopaedic trauma randomized trials. BMC Musculoskelet Disord. 2008;9:14.
16. Motulsky H. Intuitive biostatistics. Oxford: Oxford University Press; 1995. p 374.
17. Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C. Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA. 2003;289:2554-9.
18. Montori VM, Permanyer-Miralda G, Ferreira-González I, Busse JW, Pacheco-Huergo V, Bryant D, Alonso J, Akl EA, Domingo-Salvany A, Mills E, Wu P, Schünemann HJ, Jaeschke R, Guyatt GH. Validity of composite end points in clinical trials. BMJ. 2005;330:594-6.